| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $1.4M | — |
| Cost of Revenue | $1.4M | — |
| Gross Profit | $57K | — |
| R&D Expense | $27.2M | -34.9% |
| SG&A Expense | $39.9M | +33.4% |
| Operating Income | -$67.1M | +6.5% |
| Pre-tax Income | -$64.0M | +15.1% |
| Income Tax | -$1.6M | — |
| Net Income | -$62.4M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.1M | -45.9% |
| Accounts Receivable | $1.5M | — |
| Inventory | $3.3M | — |
| Current Assets | $17.4M | -36.6% |
| Total Assets | $18.6M | -35.5% |
| Current Liabilities | $45.8M | +7.7% |
| Total Liabilities | $50.8M | -50.2% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.8M | +24.7% |
| Financing Cash Flow | $45.0M | -25.4% |
| EPS (Basic) | -$1.79 | +55.9% |
| EPS (Diluted) | -$1.79 | +55.9% |
| Stockholders' Equity |
| -$32.2M |
| +56.0% |